Digestive System Disorders Clinical Trial
Official title:
Phase III - Efficacy Study of AMARGOL - Phytomedicine on Therapeutics
This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.
This study will be performed for proving the efficacy of AMARGOL®, a phytomedicine product,
under the Brazilian law for registration and revalidation RDC 14/2010.
AMARGOL® indications are for non specific digestive complaints as laxative and
anti-dyspeptic.
Is a mixture of 7 plant extracts: Aloe ferox, Angelica archangelica, Alpinia officinarum,
Cinnamomum zeylanicum, Gentiana lutea, Commiphora myrrh and Rheum palmatum.
Placebo controlled test
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01770808 -
A Study to Determine if Aquamin (as AquaCal and AquaPT) Improves Digestive Discomfort
|
N/A | |
| Completed |
NCT01405599 -
Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01405612 -
Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers
|
Phase 1 | |
| Unknown status |
NCT01318928 -
The Treatment of Periodontal Diseases
|
Phase 4 | |
| Completed |
NCT01304394 -
Safety During Use of Paediatric Triple Chamber Bag Formulas
|
Phase 3 |